NCT05951179: An ongoing trial by Protara Therapeutics
This trial is ongoing. It must report results 5 years, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05951179 |
|---|---|
| Title | A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 15, 2023 |
| Completion date | May 31, 2030 |
| Required reporting date | May 31, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |